Close
28/05/2015
Synchrotron light applications for the pharmaceutical industry
More than forty people from the pharmaceutical sector attended the workshop organised by the ALBA Synchrotron on May 7.

Researchers from the MSPD, CLAESS, XALOC, NCD and MISTRAL ALBA beam lines have shown the available state-of-the-art techniques and the advantages that they offer in this field: fast data acquisition and shorter experiments, cost savings and, in the case of X-ray microscopy, suppression of ethical conflicts because this technique can be a previous step before clinical essays with animals and persons.

The companies Enantia and Almirall, which have already collaborated with the ALBA Synchrotron, have commented their own experiences at the facility. Enantia, specialised in research solutions for other companies, has detailed different examples. For Almirall, the analysis of polymorphic compounds – performed at ALBA – has increased its quality control, verifying and quantifying purity grades.

News based on the press release issued by the ALBA synchrotron.

Image: ALBA synchrotron. Structure of a herpesvirus nuclease-antiviral complex. Data collected at the Xaloc beam line (Bongarzone, S., Nadal, M. & Coll, M., IBMB)

More news

13/12/2017 ALBA Synchrotron Works for People’s Health 01/12/2017 NanoPlastics Awarded As Best Business Idea Of The UAB University Research Park 23/11/2017 The Excellence of Natura Bissé Awarded by Forbes Travel Guide 08/11/2017 SENER, 50 Years in Space and Ambitious Projects Such As the E-ELT Telescope 02/11/2017 The Barcelona Synchrotron Park in the SmartReFlex European project 26/10/2017 New Findings on Malaria Thanks to ALBA Synchrotron
13 14 15 16 17 18 19 20 21 22 23